FindTrial
Sign In

Clinic study of nucleus pulposus cell transplantation in the treatment of lumbar intervertebral disc protrusion

Clinic study of discectomy and transplantation of autologous nucleus pulposus cell in the treatment of lumbar intervertebral disc protrusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003387
Enrollment
Unknown
Registered
2013-06-13
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protrusion of intervertebral disc

Interventions

test:autologous nucleus pulposus cell transplantation combined with excision of nucleus pulposus

Sponsors

Navy General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients, from 18 to 50 years old, have a single segmental intervertebral disc herniation; 2. There is no therapeutic effect through conservative treatment more than 3 months; 3. Body mass index is more than 20 and less than 28.

Exclusion criteria

Exclusion criteria: 1. including osteophyte formation, ligament ossification, segmental instability, spondylolisthesis and other systemic diseases which could affect operation effect and prognosis; 2. mental disorder.

Design outcomes

Primary

MeasureTime frame
X-ray;MRI of the spine;JOA Score;SF36 Score;VAS score;—

Secondary

MeasureTime frame
ODI Score;—

Countries

China

Contacts

Public ContactRuan Dike
ruandike@yahoo.com.cn+86 18600310015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026